Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.
about
Retroviral superinfection resistance.Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected SubjectsStampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDSEmergence of recombinant forms of HIV: dynamics and scalingAnalysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, BrazilHIV/AIDS epidemiology, pathogenesis, prevention, and treatmentImpact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA InteractionThe indonesian variants of CRF33_01B: Near-full length sequence analysisHIV dynamics with multiple infections of target cells.Genic incompatibilities in two hybrid bacteriophagesA strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission.Feline immunodeficiency virus (FIV) env recombinants are common in natural infections.In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants by using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitors.Characteristics of high-risk HIV-positive IDUs in Vietnam: implications for future interventions.Frequent intra-subtype recombination among HIV-1 circulating in TanzaniaHIV variability in the liver and evidence of possible compartmentalization.The role of self-efficacy and motivation to explain the effect of motivational interviewing time on changes in risky sexual behavior among people living with HIV: a mediation analysis.Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trial.The impact of alcohol use on the sexual scripts of HIV-positive men who have sex with men.Genetic and functional characterization of HIV-1 Vif on APOBEC3G degradation: First report of emergence of B/C recombinants from North India.Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeq.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.Advances in FIV vaccine technology.Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation.Improving HIV rapid testing rates among STD clinic patients: a randomized controlled trialThe challenge of HIV-1 subtype diversity.Does motivational interviewing counseling time influence HIV-positive persons' self-efficacy to practice safer sex?The remarkable frequency of human immunodeficiency virus type 1 genetic recombinationMolecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implicationsRole of GB virus C in modulating HIV diseaseAntagonistic within-host interactions between plant viruses: molecular basis and impact on viral and host fitness.In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity.Dynamical properties and thresholds of an HIV model with super-infection.Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.Recombination among GB virus C (GBV-C) isolates in the United States.Complete genome sequencing and characterization revealed a recombinant subgroup B isolate of avian leukosis virus with a subgroup J-like U3 region.Functional effector memory T cells contribute to protection from superinfection with heterologous simian immunodeficiency virus or simian-human immunodeficiency virus isolates in Chinese rhesus macaques.HIV Awareness and Knowledge among Viewers of a Documentary Film about HIV among Racial- or Ethnic-Minority Older Adults.Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in GermanyHuman pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda.
P2860
Q24815564-EB0179E5-585D-43FF-96C6-E3D695054B1FQ27468827-B314C65A-5CE4-484C-B63F-CC9BFD71A8F1Q28260539-EEACD539-38FF-439D-A506-BF7837775FE7Q28469341-2F795CE8-869F-499C-8227-7F71CE5A53C1Q28538304-D07421F7-B8E3-48A7-B7DE-4015021E6976Q30356074-B89CB6AE-5D7B-4367-9361-0744748B67C9Q33587964-B7DCBAFF-688A-4985-A443-E10B1088F8FEQ33722467-7E98843E-A4F1-4750-B9C0-310E88477BA6Q33852032-56CB4594-BD61-4D7C-87C4-7A9A9FA10882Q34029760-DCD87E9C-93AA-4892-8EB9-BAB03E8D5E49Q34118295-D7E2AC88-C064-4DDA-9D28-A4C4BA341872Q34270843-367A536B-D0AD-4525-866F-8F4CD8FFA60AQ34296101-74C775B2-C39D-44CE-A09E-5C7E1DFE9214Q34367568-B326A3AB-2D07-47EE-A40C-B42FE0C5F4D4Q34936859-1A0ADE7E-F906-470D-B82D-DDEB0227CFE8Q35267884-017D7960-EB33-4D07-A3D8-01573E923BB6Q35454937-92D4C6E4-CB7F-48F0-AD93-44908F433B8BQ35998938-003F1D03-15DE-4B40-90E0-8FAB00715B3AQ36086784-2857E838-2149-4D3E-B5FE-C52AA6315770Q36192427-C9B29F35-B922-49C0-A5C0-26217687C022Q36271817-272C5DAE-1B5A-474B-B4FD-F1D49B651295Q36473694-C2182386-88DA-4F5A-AC1A-C58DD8D6AD0DQ36634847-0B38B61E-48B1-416B-864E-1D8122D0492AQ36899989-F879F615-B029-47AE-9C1D-C316AE4CA011Q36995661-9DCBA0D7-B78F-4B8E-A691-6A40EF341BA5Q37038453-715DCCEA-6FF4-4FF7-9478-EE3B5CA3D91DQ37196076-AAF9592F-F404-4CA0-9A58-28B52D803A54Q37333701-A8344283-8450-45CD-9CA8-261BF1CE4950Q37509718-D5434895-2075-4818-AB22-850A5EEC0A04Q38018981-05EC0B19-C3F8-4D27-A77A-668FD75E3596Q38594823-4FB0BD2C-737A-446D-A479-9E70A20B7945Q38604868-22EA77FA-6B25-4D07-83C0-821E3E3F9BABQ39208948-4D1233D2-5A86-499C-ACA2-D58AA9D77D17Q39593653-6A2F71D3-5F9C-43BC-A198-30D9B9A2CB61Q39855368-5D724F3F-A4EF-4FD4-BE5A-FF9E66B64C79Q40118975-31318506-9750-4422-9418-15E1197BBA24Q40362873-FBD4D7C7-ADBB-4338-9B24-F921D0A265ADQ41045924-133662A9-36DA-4137-926B-AF5F605406DCQ42101853-EA8A7B38-BA39-4366-A40B-025AD8DC6A61Q46643751-30DBB2A0-1EC1-48A4-9F25-64078B3F50DE
P2860
Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human immunodeficiency virus s ...... tential clinical consequences.
@ast
Human immunodeficiency virus s ...... tential clinical consequences.
@en
Human immunodeficiency virus s ...... tential clinical consequences.
@nl
type
label
Human immunodeficiency virus s ...... tential clinical consequences.
@ast
Human immunodeficiency virus s ...... tential clinical consequences.
@en
Human immunodeficiency virus s ...... tential clinical consequences.
@nl
prefLabel
Human immunodeficiency virus s ...... tential clinical consequences.
@ast
Human immunodeficiency virus s ...... tential clinical consequences.
@en
Human immunodeficiency virus s ...... tential clinical consequences.
@nl
P2860
P356
P1476
Human immunodeficiency virus s ...... tential clinical consequences.
@en
P2093
Daniel E Cohen
Jason T Blackard
P2860
P304
P356
10.1086/339547
P407
P577
2002-03-15T00:00:00Z